Datasetsmetadata only
ClinicalTrials.gov
clinicaltrials · Datasets · License: Public Domain
19,622Documents
0Full text
2026-09-07Last indexed
Recent documents from this source
- Study of AV-1959D, an Amyloid Beta Vaccine#628588
- Open Label Immunotherapy Trial for Ovarian Cancer#628587
- BCG Vaccination to Prevent COVID-19#628586
- Safety and Tolerability Study of V501 in Japanese Boys (V501-200)#628585
- WT1 Vaccine Treatment of Patients in Remission From Acute Myeloid Leukemia (AML) or Acute Lymphoblastic Leukemia (ALL)#628584
- Regimen Optimization Trial of PfSPZ Vaccine in Equatorial Guinea#628583
- Adjuvanted Influenza Vaccine Evaluation in Kidney Transplant Recipients#628582
- Evaluating the Safety, Tolerability, and Pharmacokinetics of Bedaquiline and Delamanid, Alone and in Combination, For Drug-Resistant Pulmonary Tuberculosis#628581
- Ezrin Peptide (HEP-1) for Treatment of Coronavirus Disease (COVID-19) Infection#628580
- A Study of a New Leishmania Vaccine Candidate ChAd63-KH#628579
- Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia in Remission#628578
- PROmotion of COVID-19 BOOSTer VA(X)Ccination in the Emergency Department - PROBOOSTVAXED#628577
- A Surveillance Study of Diseases Specified as Adverse Events of Special Interest, of Other Adverse Events Leading to Hospitalisation or Death, and of Meningitis in Children in Africa Prior to Implementation of the RTS,S/AS01E Candidate Vaccine#628576
- Vaccine Therapy Compared With Interferon Alfa in Treating Patients With Stage III Melanoma#628575
- Clinical Trial of IL - 22BP Safety, Tolerability, and Antitumor Activity in Refractory Solid Tumors.#628574
- The Phase IVd of Inactivated Enterovirus 71 Vaccine#628573
- Immunogenicity of the Booster Dose of Two MenC Vaccines#628572
- Trial to Evaluate the Safety and Immunogenicity of 3 Lots of 20-valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-Naïve Adults#628571
- A Study of mRNA-1020 and mRNA-1030 Seasonal Influenza Vaccines in Healthy Adults#628570
- Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Meningococcal Conjugate Vaccine (GSK134612) When Co-administered With Boostrix® in Subjects Between 11 and 25 Years of Age#628569
Source record · clinicaltrials · Datasets · License: Public Domain
Conceptio Open Knowledge Archive — counts are materialised per sync from the index (real full-text coverage, never license entitlement).